Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

Correlating Ic/Pbs Symptoms With Urine Biomarkers

NCT00817388 ·Status: COMPLETED

Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis

NCT01479725 ·Status: COMPLETED ·Phase: PHASE2

Urinary Biomarkers Characteristic to Interstitial Cystitis

NCT00971568 ·Status: COMPLETED

The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)

NCT02331472 ·Status: COMPLETED

Autonomic Response During Cystodistension in Patients Suspected of Having Interstitial Cystitis

NCT01301365 ·Status: UNKNOWN

Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis

NCT01138800 ·Status: COMPLETED

The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome

NCT01985880 ·Status: COMPLETED

Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic Characteristics (ICEPAC) Study

NCT01616992 ·Status: COMPLETED

Intravesical Liposomes for Ulcerative Cystitis

NCT01083979 ·Status: COMPLETED ·Phase: NA

Sacral Neuromodulation in Patients With IC

NCT00590473 ·Status: COMPLETED ·Phase: NA

Sensory Sensitivity and Urinary Symptoms in the Female Population

NCT01978002 ·Status: COMPLETED

The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients

NCT03722992 ·Status: COMPLETED ·Phase: NA

Interstitial Cystitis: Examination of the Central Autonomic Network

NCT03008382 ·Status: COMPLETED ·Phase: PHASE4

Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.

NCT00775281 ·Status: COMPLETED

Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

NCT02870738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Sensory Processing in Subjects With Painful Bladder Syndrome

NCT00903643 ·Status: COMPLETED

Interstitial Cystitis and Urinary pH

NCT03024619 ·Status: COMPLETED

A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.

NCT00527917 ·Status: COMPLETED ·Phase: PHASE2

Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC

NCT05223244 ·Status: COMPLETED ·Phase: PHASE4

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

NCT04734847 ·Status: RECRUITING ·Phase: NA

COVID-19 Vaccines and the Development of New LUTS

NCT05582525 ·Status: COMPLETED

S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain

NCT03003845 ·Status: COMPLETED

Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)

NCT01731470 ·Status: COMPLETED ·Phase: NA

A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome

NCT02868775 ·Status: UNKNOWN

Genetic and Histopathologic Characteristics of Interstitial Cystitis

NCT03523559 ·Status: COMPLETED